Medifast Inc MED.N, MED is expected to show a fall in quarterly revenue when it reports results on August 4 for the period ending June 30 2025
The Baltimore Maryland-based company is expected to report a 43.0% decrease in revenue to $96.1 million from $168.56 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on April 28 2025, for the period ended June 30, was for revenue between $85.00 million and $105.00 million.
LSEG's mean analyst estimate for Medifast Inc is for a loss of 22 cents per share. The company's EPS guidance on April 28 2025, for the period ended June 30, was between $-0.55 and $0.00
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Medifast Inc is $15.00, about 8.3% above its last closing price of $13.75
This summary was machine generated August 1 at 20:53 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)